ZA9810759B - Proliferatively active product for treating proliferating cells. - Google Patents

Proliferatively active product for treating proliferating cells.

Info

Publication number
ZA9810759B
ZA9810759B ZA9810759A ZA9810759A ZA9810759B ZA 9810759 B ZA9810759 B ZA 9810759B ZA 9810759 A ZA9810759 A ZA 9810759A ZA 9810759 A ZA9810759 A ZA 9810759A ZA 9810759 B ZA9810759 B ZA 9810759B
Authority
ZA
South Africa
Prior art keywords
proliferating cells
active product
proliferatively active
treating proliferating
treating
Prior art date
Application number
ZA9810759A
Inventor
Christopher Ralph Franks
Ruggero Della Bitta
Original Assignee
Bioinnovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioinnovation Ltd filed Critical Bioinnovation Ltd
Publication of ZA9810759B publication Critical patent/ZA9810759B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/642Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA9810759A 1997-11-26 1998-11-25 Proliferatively active product for treating proliferating cells. ZA9810759B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9724838.9A GB9724838D0 (en) 1997-11-26 1997-11-26 Compositions

Publications (1)

Publication Number Publication Date
ZA9810759B true ZA9810759B (en) 2000-05-25

Family

ID=10822573

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810759A ZA9810759B (en) 1997-11-26 1998-11-25 Proliferatively active product for treating proliferating cells.

Country Status (8)

Country Link
EP (1) EP1032427A2 (en)
JP (1) JP2001523731A (en)
AU (1) AU1249999A (en)
CA (1) CA2311733A1 (en)
GB (1) GB9724838D0 (en)
NZ (1) NZ504625A (en)
WO (1) WO1999026660A2 (en)
ZA (1) ZA9810759B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003501402A (en) * 1999-06-03 2003-01-14 バイオイノベイション・リミテッド Gene therapy products
US7517887B2 (en) * 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
US7868011B2 (en) 2003-04-09 2011-01-11 General Atomics Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
US7196093B2 (en) 2003-04-09 2007-03-27 General Atomics Reversible inhibitors of SAH hydrolase and uses thereof
CA2828657A1 (en) 2011-03-11 2012-09-20 Assistance Publique - Hopitaux De Paris Use of low dose il-2 for treating autoimmune - related or inflammatory disorders
US9669071B2 (en) 2011-03-11 2017-06-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for stimulating T lymphocytes with IL-2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318948B1 (en) * 1987-12-02 1992-08-19 Neorx Corporation Cleavable immunoconjugates for the delivery and release of agents in native form
CA2016584C (en) * 1989-05-17 1999-06-29 Robert S. Greenfield Anthracycline conjugates having a novel linker and methods for their production
JP3105629B2 (en) * 1991-04-23 2000-11-06 サングスタット メディカル コーポレイション Cell activity regulating conjugates of members of specific binding pairs
US5248499A (en) * 1991-10-07 1993-09-28 Genentech, Inc. Control of microbial infections in transplant patients
US6214345B1 (en) * 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
US5635599A (en) * 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands

Also Published As

Publication number Publication date
AU1249999A (en) 1999-06-15
CA2311733A1 (en) 1999-06-03
WO1999026660A3 (en) 1999-10-14
NZ504625A (en) 2002-12-20
EP1032427A2 (en) 2000-09-06
WO1999026660A2 (en) 1999-06-03
GB9724838D0 (en) 1998-01-21
JP2001523731A (en) 2001-11-27

Similar Documents

Publication Publication Date Title
ZA9610870B (en) Electroconversion cell.
HK1040161A1 (en) Synergistic insecticide mixturesantisense oligonucleotides for treating proliferating cells
ZA9811075B (en) Absorbent article.
SG63814A1 (en) Thin type cell
ZA992549B (en) Incorporation of active substances in carrier matrixes.
ZA965381B (en) Electrochemical cell.
ZA981842B (en) Treated horticultural substrates.
ZA98111B (en) Absorbent products having conforming means.
ZA9811836B (en) Belt pack.
HUP0002248A3 (en) Tablets, and process for making tablets
ZA985184B (en) Bleaching enzymes.
ZA975961B (en) Carrier for pastry.
EP0679402A3 (en) Biologically active substance-secreting hybrid gel.
ZA96960B (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
EP0674243A3 (en) Donor roll.
ZA9711103B (en) Plant support.
EP1002793A4 (en) Physiologically active substances tkr2449, process for producing the same, and microorganism
ZA9810759B (en) Proliferatively active product for treating proliferating cells.
ZA965191B (en) Cell treatment
ZA967385B (en) Stabilized absorbent article.
ZA966803B (en) Cell culture products.
GB9714936D0 (en) Cell culture products
GB9912851D0 (en) Treating cells
AU6006800A (en) Treating cells
GB9603431D0 (en) Immunodulating active substance